chr6-156778292-A-ACAGCAGCAGCAG

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP3BP6_Very_StrongBS2_Supporting

The NM_001374828.1(ARID1B):​c.624_635dupGCAGCAGCAGCA​(p.Gln209_Gln212dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,518,258 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q212Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000041 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000030 ( 0 hom. )

Consequence

ARID1B
NM_001374828.1 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.46

Publications

12 publications found
Variant links:
Genes affected
ARID1B (HGNC:18040): (AT-rich interaction domain 1B) This locus encodes an AT-rich DNA interacting domain-containing protein. The encoded protein is a component of the SWI/SNF chromatin remodeling complex and may play a role in cell-cycle activation. The protein encoded by this locus is similar to AT-rich interactive domain-containing protein 1A. These two proteins function as alternative, mutually exclusive ARID-subunits of the SWI/SNF complex. The associated complexes play opposing roles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
ARID1B Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina, ClinGen
  • Coffin-Siris syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001374828.1
BP6
Variant 6-156778292-A-ACAGCAGCAGCAG is Benign according to our data. Variant chr6-156778292-A-ACAGCAGCAGCAG is described in ClinVar as Likely_benign. ClinVar VariationId is 589511.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 6 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001374828.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARID1B
NM_001374828.1
MANE Select
c.624_635dupGCAGCAGCAGCAp.Gln209_Gln212dup
disruptive_inframe_insertion
Exon 1 of 20NP_001361757.1
ARID1B
NM_001438482.1
c.624_635dupGCAGCAGCAGCAp.Gln209_Gln212dup
disruptive_inframe_insertion
Exon 1 of 21NP_001425411.1
ARID1B
NM_001438483.1
c.624_635dupGCAGCAGCAGCAp.Gln209_Gln212dup
disruptive_inframe_insertion
Exon 1 of 21NP_001425412.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARID1B
ENST00000636930.2
TSL:2 MANE Select
c.624_635dupGCAGCAGCAGCAp.Gln209_Gln212dup
disruptive_inframe_insertion
Exon 1 of 20ENSP00000490491.2
ARID1B
ENST00000346085.10
TSL:1
c.624_635dupGCAGCAGCAGCAp.Gln209_Gln212dup
disruptive_inframe_insertion
Exon 2 of 21ENSP00000344546.5
ARID1B
ENST00000350026.11
TSL:1
c.624_635dupGCAGCAGCAGCAp.Gln209_Gln212dup
disruptive_inframe_insertion
Exon 1 of 19ENSP00000055163.8

Frequencies

GnomAD3 genomes
AF:
0.0000413
AC:
6
AN:
145298
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000550
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000202
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000447
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000299
AC:
41
AN:
1372960
Hom.:
0
Cov.:
37
AF XY:
0.0000251
AC XY:
17
AN XY:
677774
show subpopulations
African (AFR)
AF:
0.0000713
AC:
2
AN:
28048
American (AMR)
AF:
0.00
AC:
0
AN:
35068
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24812
East Asian (EAS)
AF:
0.000230
AC:
8
AN:
34778
South Asian (SAS)
AF:
0.0000255
AC:
2
AN:
78520
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
42484
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5526
European-Non Finnish (NFE)
AF:
0.0000272
AC:
29
AN:
1066902
Other (OTH)
AF:
0.00
AC:
0
AN:
56822
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.412
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000413
AC:
6
AN:
145298
Hom.:
0
Cov.:
31
AF XY:
0.0000422
AC XY:
3
AN XY:
71036
show subpopulations
African (AFR)
AF:
0.0000550
AC:
2
AN:
36340
American (AMR)
AF:
0.00
AC:
0
AN:
14968
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3414
East Asian (EAS)
AF:
0.000202
AC:
1
AN:
4958
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4774
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10448
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
306
European-Non Finnish (NFE)
AF:
0.0000447
AC:
3
AN:
67182
Other (OTH)
AF:
0.00
AC:
0
AN:
1998
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Jan 25, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

not provided Benign:1
Apr 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.5
Mutation Taster
=77/23
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587779744; hg19: chr6-157099426; API